Surgical activity regulation in the operating room leads to improved scheduling accuracy and more effective resource management, which results in decreased operational time and increased efficiency. ja.ma/4cFNYVO

A true friend is never truly gone... Their spirit lives on in the memories of those who loved them. Thank you Michael for the good times, the laughs and the love you shared with us. 🤍In memory of our friend and colleague Michael Frumovitz🤍 Pedro T Ramirez Arthur_HC_Hsu

Bariatric surgery was associated with a reduced risk of breast cancer in women with obesity. The risk reduction was strongest in women with high insulin levels at baseline. ja.ma/4fOTLKs

Excited to share our latest editorial in IJGC on navigating the complexities of AI in scientific writing. A huge thanks to my amazing co-authors Gabriel Levin and Sabrina Piedimonte #AI #Oncology #Researchpaper Pedro T Ramirez Houston Methodist MD ijgc.bmj.com/content/early/…

🚨 #Highlights from #ESGO2023 in Barcelona! 🇪🇸 New research findings & expert panel discussions are shaping the future of gynaecological oncology. 🔬👩‍⚕ Don't miss the ENYGO-IJGC Fellow conversations for in-depth perspectives! 👉 Join the discussion: bit.ly/4gYwgzl

🎉 Congratulations on receiving the #IJGC Top Reviewer Award! Thank you for setting the standard of excellence! 👏🤩 #TopReviewerAward #IGCS2024 Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc

so humbled to have received this incredible recognition! thank you IJGC

Live from New York, it's Saturday night.

Anastomotic diversion rates following integration of indocyanine green 🍏 fluorescence angiography in cytoreductive surgery for #ovariancancer ✅ bit.ly/3O92j2a Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert

first day of #RGOQ success!! Thank you Mario M. Leitao, Jr for the great keynote presentation on primary cytoreductive surgery And Elisabeth Spénard 🥂 to our Tiffany & Co. fellowship bracelets

📻 Join us for our latest #podcast episode discussing #KEYNOTE-A18, which explores the addition of #pembrolizumab to #chemoradiation in #CervicalCancer treatment by Dr Domenica Lorusso Link @ bit.ly/4eCzhD5 Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes

One final thank you ❤️

Our 15-year cohort study explores trends in surgical de-escalation in gynecologic oncology. These findings are transforming patient care but raise important questions about the preparation of fellows in surgical training. Alex Melamed David Viveros-Carreño J. Alejandro Rauh-Hain, MD, MPH Roni Nitecki Wilke

Truly a sad day! Was just together with him a few weeks ago! True leader in Italy and Europe and world! Will be missed!

🚨The #2025SpecialIssue is HERE!🚨 📢 This March, we’re diving deep into the controversies in managing rare #GynecologicalCancers Enjoy 🆓 access all month! Don’t miss out—read, share, and join the conversation! 🔗 bit.ly/43DMppN Pedro T Ramirez Arthur_HC_Hsu

🎉 Thrilled to share MM-OR has been accepted to #CVPR2025. MM-OR is a new, large scale multimodal operating room dataset for semantic understanding of surgeries. It captures robotic knee replacement surgeries with multi-view RGB-D video, audio, speech transcripts, robotic logs,

Integrating clinical-molecular data 📊 to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery SGO IGCS ESGO International Society of Gynecologic Pathologists OncoAlert sciencedirect.com/science/articl…

Small cell carcinoma of the cervix with syndrome of inappropriate antidiuretic hormone secretion following chemotherapy 💊 SGO IGCS ESGO ASCO OncoAlert Sabrina Piedimonte sciencedirect.com/science/articl…

Artificial intelligence in the diagnosis & management of gynecologic cancer pubmed.ncbi.nlm.nih.gov/40277295/ AI presents significant potential to improve outcomes in Gyn oncology, particularly in bridging healthcare gaps in resource-limited settings.Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Bottom line from the #ctDNA analyses in CALLA study in #CervicalCancer (addition of durva to chemoradiation) 👀 Low ctDNA both at baseline and after completion of chemoXRT associated with better survival 🤔 ctDNA status was most significant prognostic factor #ASCO25 #gyncsm